U.S. pharma giant copyright scrapped two experimental weight loss pills last year—a after-each day pill, lotiglipron, as a result of elevated liver enzymes and also a twice-every day pill, danuglipron, as a result of powerful Unwanted effects—but CEO Albert Bourla has explained the c